Lion Point Capital »

Moonlake Immunot shares owned by Lion Point Capital

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $484k 68k 7.17

More positions owned by Lion Point Capital

Mineralys Therapeutics (MLYS)
Milestone Pharmaceuticals (MIST)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Avadel Pharmaceuticals Com Shs (AVDL)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Insmed Com Par $.01 (INSM)
Ardelyx (ARDX)
Benitec Biopharma Com New (BNTC)
Syndax Pharmaceuticals (SNDX)
Royalty Pharma Shs Class A (RPRX)
Disc Medicine (IRON)
Bridgebio Pharma (BBIO)
Geron Corporation (GERN)
Arcutis Biotherapeutics (ARQT)

View all positions for Lion Point Capital

Top funds holding Moonlake Immunot

BVF
venBio Select Advisor
Cormorant Asset Management
Balyasny Asset Management
Adage Capital Partners GP
Ikarian Capital
Schonfeld Strategic Advisors
Susquehanna International
Jane Street
Boothbay Fund Management
Caption Management
FMR
Nuveen
Citadel Advisors
Two Sigma Investments

View all funds holding Moonlake Immunot